Voiding Dysfunction and Reconstructive Surgery, University of Mississippi Medical Center, Jackson, MS.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
Urology. 2023 Oct;180:190-193. doi: 10.1016/j.urology.2023.07.016. Epub 2023 Jul 27.
To determine if hypogonadism leads to delayed urinary function recovery post-radical prostatectomy (RP) by studying the effect of preoperative factors including age, membranous urethral length, radiation therapy, and Body Mass Index on urinary continence in patients with or without hypogonadism.
We identified 1209 patients treated by RP with both pretreatment T and post-treatment urinary outcome. We assessed whether there was an association between low preoperative T level (prenoon T ≤ 300 ng/dL) and continence (using ≤1 pad/d) at 6 and 12months post-RP. Patient-reported continence was used when available, otherwise, surgeon-assessed continence was used. Logistic regression models were used, adjusted for age at RP and nerve-sparing status.
Median age at RP was 61 (Intraquatile Range (IQR) 56, 66), 92% of patients had at least one nerve spared and 99% were continent at baseline. Continence in patients with low T was nonsignificantly lower at 6months (odds ratio 0.69, 95% confidence interval 0.44, 1.06; P = .10) and nonsignificantly higher at 12months (odds ratio 1.07, 95% confidence interval 0.71, 1.58; P = .8). Sensitivity analyses excluding patients with preoperative metastasis or treated with androgen deprivation therapy (ADT) and including testosterone as a continuous predictor were consistent with the primary analysis; similarly finding no evidence of an association.
Although we cannot rule out an effect on early continence, overall the evidence does not suggest that low serum testosterone adversely impacts urinary function recovery after RP. This finding can be used to counsel patients enrolled in neoadjuvant ADT trials or those patients undergoing RP who have had prior ADT, such as in the setting of oligometastatic disease.
通过研究术前因素(包括年龄、膜部尿道长度、放疗和体重指数)对去势治疗前列腺癌根治术后(RP)尿控的影响,确定性腺功能减退是否导致 RP 后尿功能恢复延迟。
我们鉴定了 1209 例接受 RP 治疗且术前 T 水平和术后尿控结局均完整的患者。我们评估了术前低 T 水平(上午 T 水平≤300ng/dL)与 RP 后 6 个月和 12 个月时尿控(使用≤1 片尿垫/天)之间是否存在相关性。当患者报告的尿控情况可用时,采用患者报告的尿控情况;否则,采用手术医生评估的尿控情况。使用逻辑回归模型,校正 RP 时的年龄和神经保留状态。
RP 时的中位年龄为 61 岁(四分位间距 56,66),92%的患者至少保留了一根神经,99%的患者在基线时是尿控的。T 水平低的患者在 6 个月时的尿控率略低(比值比 0.69,95%置信区间 0.44,1.06;P=0.10),在 12 个月时的尿控率略高(比值比 1.07,95%置信区间 0.71,1.58;P=0.8)。排除术前转移或接受雄激素剥夺治疗(ADT)的患者以及将睾酮作为连续预测因子的敏感性分析与主要分析结果一致;同样未发现与血清睾酮水平之间存在关联的证据。
尽管我们不能排除对早期尿控的影响,但总体证据表明,低血清睾酮水平不会对 RP 后尿功能恢复产生不利影响。这一发现可用于指导新辅助 ADT 试验入组患者或那些已经接受过 ADT(如寡转移疾病)的 RP 患者。